Individuals who visited the ER for substance-induced psychosis had a 160% greater risk of developing a schizophrenia spectrum disorder (SSD) compared with the general population, new research shows. Three years after an initial ER visit, 18.5% of those with substance-induced psychosis were diagnosed with an SSD. Cannabis-induced psychosis was associated with the greatest risk.
Eve Bender. Substance-Induced Psychosis Tied to Schizophrenia Risk – Medscape – Oct 04, 2023 – https://www.medscape.com/viewarticle/997093
schizophrenia
Olanzapine – Think Bipolar and Schizophrenia
Medical News: FDA Okays Generic Version of Zyprexa – in Psychiatry, Schizophrenia from MedPage Today
The FDA has approved a generic version of atypical antipsychotic drug olanzapine (Zyprexa) to treat schizophrenia and bipolar disorder.
According to the AP story:
Drugs like Zyprexa can cost up to $500 per month. Generic versions can cut the cost by up to 80 percent.
This is great news.
Not Just Bad Wiring – Schizophrenia
Saphris – Think Schizophrenia or Bipolar
I suppose Saphris sounds better than asenapine.
FDA approval was based on data from more than 3,000 patients showing statistically significant efficacy versus placebo in acute schizophrenia trials and statistically significant reduction of bipolar mania symptoms versus placebo.
Son of Risperdal (risperidone)
Question of the Day
So what should the mortality rating be for a first degree relative who inhabits the same dwelling of a schizophrenic with substance abuse?
lifeunderwriter.net 